Extract from our M&A Insights

Read more about our Nordic and DACH M&A Insights services including the M&A Portal and Private Equity Portfolio Tracker.
Leo Pharma invests USD 0.5m in Microbiome technology
April 13, 2018

The medical company Leo Pharma invests USD 0.5m in the American company Naked Biome, which develops treatments for skin diseases. As part of the agreement, Leo Pharma will be part of the Naked Biome Advisory Board focusing on counseling in clinical plans and formulation development, according to the press release.

ⓘ This story was originally featured in our daily Nordic M&A Newsletter - we publish some of the newsletter content with delay through our M&A Newsletter Library. If you would like more insights on this deal or industry then send us an email at requests@nordicknowledgepartners.com